What is the recommended format for writing a final diagnosis of Henoch-Schonlein purpura (HSP)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Writing the Final Diagnosis of Henoch-Schönlein Purpura

The final diagnosis of Henoch-Schönlein purpura should be written as "IgA vasculitis (Henoch-Schönlein purpura)" with specification of the pattern of organ involvement, including the presence or absence of nephritis, and supported by histopathological confirmation showing IgA-dominant immune complex deposition in affected tissues. 1, 2

Diagnostic Format Structure

Primary Diagnosis Statement

  • Write the primary diagnosis as: "IgA vasculitis (Henoch-Schönlein purpura)" or simply "Henoch-Schönlein purpura" 3, 2
  • This reflects the current understanding that HSP is fundamentally an IgA-mediated small vessel vasculitis 3, 4

Pattern of Organ Involvement

Document the specific organ systems affected, following a systematic approach similar to glomerulonephritis diagnostic reporting 1:

  • Cutaneous involvement: Specify presence of palpable purpura, typically on lower extremities and buttocks 1, 5
  • Renal involvement: If present, specify as "HSP with nephritis" or "IgA vasculitis with glomerulonephritis" 3, 2
  • Gastrointestinal involvement: Document presence of abdominal pain, bleeding, or other GI manifestations 4, 5
  • Joint involvement: Note arthralgia or arthritis if present 5, 6
  • Other organ systems: Include any pulmonary, cardiac, neurological, or genitourinary complications if present 3, 4

Histopathological Confirmation

The diagnosis should include reference to biopsy findings when available 1, 2:

  • For skin biopsy: "Leukocytoclastic vasculitis with IgA-dominant immune complex deposition" 2
  • For renal biopsy (if nephritis present): "Mesangial proliferative glomerulonephritis with IgA-dominant deposits" following the format used for IgA nephropathy 1

Clinical Modifiers

Add clinical context that affects prognosis or management 1:

  • Age of patient (pediatric vs. adult, as adults have more severe disease) 3, 4
  • Severity of renal involvement (if present): mild hematuria vs. nephrotic-nephritic syndrome 2
  • Presence of crescentic glomerulonephritis (indicates severe disease requiring potential immunosuppression) 7

Example Diagnostic Statements

Complete Format (with renal involvement):

Primary diagnosis: IgA vasculitis (Henoch-Schönlein purpura) with nephritis 1, 2

Pattern of involvement: Cutaneous purpura, arthralgia, and mesangial proliferative glomerulonephritis 1

Histopathology: Skin biopsy showing leukocytoclastic vasculitis with IgA-dominant immune deposits; renal biopsy showing mesangial proliferative glomerulonephritis with IgA deposits 1, 2

Additional features: Adult presentation with nephrotic-range proteinuria 3, 4

Simplified Format (without renal involvement):

Primary diagnosis: IgA vasculitis (Henoch-Schönlein purpura) 2

Clinical features: Palpable purpura of lower extremities, arthralgia, abdominal pain 5

Histopathology: Skin biopsy confirming leukocytoclastic vasculitis with IgA deposits 2

Critical Diagnostic Considerations

Importance of Tissue Confirmation

  • Skin biopsy with immunofluorescence is essential for definitive diagnosis, as IgA deposits in vessel walls are sine qua non for HSP diagnosis 2
  • Clinical diagnosis alone can lead to missed diagnoses or overdiagnosis, resulting in inappropriate follow-up or missed chronic renal failure 2
  • Renal biopsy is indicated when diagnosis is uncertain, atypical presentation occurs, or when there is severe nephritis 7, 2

Common Diagnostic Pitfalls

  • Avoid diagnosing HSP based solely on clinical criteria without histopathological confirmation, as other leukocytoclastic vasculitides can mimic HSP 2, 6
  • Do not overlook delayed renal manifestations—nephritis can appear years after initial presentation 2
  • Remember that incomplete clinical pictures are common; not all patients present with the classic tetrad of purpura, arthritis, abdominal pain, and nephritis 5, 6

Differential Diagnosis Exclusion

Document that other causes have been excluded 7:

  • ANCA-negative (to exclude ANCA-associated vasculitis) 1, 7
  • Anti-GBM antibody-negative 7
  • Normal complement levels (C3, C4) or document if abnormal 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Diagnosis of Henoch-Schönlein purpura: renal or skin biopsy?

Pediatric nephrology (Berlin, Germany), 2003

Research

[Henoch-Shönlein purpura].

Nephrologie & therapeutique, 2009

Research

[Henoch-Schönlein purpura].

La Revue du praticien, 2008

Research

Henoch-Schönlein purpura.

Current opinion in rheumatology, 1994

Guideline

Management of Post-Streptococcal Glomerulonephritis (PSGN)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.